Greater efficiency in the process of matching patients to appropriate providers is vital to achieving the Triple Aim. As patients research and choose among appropriate providers, sound decision-making will depend on the accessibility of high-quality data that enables them to make meaningful, actionable comparisons. Online public-reporting tools, such as those published by U.S. News, CMS and others, serve as venues for consumer decision-making. Driven by current trends in data transparency, rapid advances in public reporting can be anticipated. This presentation will outline several recent and expected future developments in the evolution of key public-reporting tools, and discuss their role in facilitating patient engagement and access to appropriate care.
March 02, 2018
Value-based health care is one of the most pressing topics in health care finance and policy today. Value-based payment structures are widely touted as critical to controlling runaway health care costs, but are often difficult for health care entities to incorporate into their existing infrastructures. Because value-based health care initiatives have bipartisan support, it is likely that these programs will continue to play a major role in both the public and private health insurance systems. As such, there is a pressing need to evaluate the implementation of these initiatives thus far and to discuss the direction that American health care financing will take in the coming years.
To explore this important issue, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School collaborated with Ropes & Gray LLP to host a one-day conference on value-based health care. This event brought together scholars, health law practitioners, and health care entities to evaluate the impact of value-based health care on the American health care system.
For more information, visit our website at: http://petrieflom.law.harvard.edu/events/details/will-value-based-care-save-the-health-care-system
Enhancing the patient experience in a new purpose-build MDT meeting room with...Cancer Institute NSW
St Vincent’s Head and Neck Clinic is a well-established, multidisciplinary clinic which has provided a co-ordinated team approach to the head and neck patient’s complex needs for over three decades. With the development of a new, purpose-built cancer facility, a clinical redesign project was undertaken, with the aim to further enhancing the patient experience and improving the quality of care for patients attending the weekly Multidisciplinary Head and Neck Clinic.
An integrated model of psychosocial cancer care: a work in progress…Cancer Institute NSW
Cancer patients are faced with a multitude of stressors, from diagnosis, through treatment, at recurrence, in the stages following treatment completion, and in the terminal phase. Psychosocial care has been highlighted as a critical aspect of providing comprehensive patient-focused care. Specifically, one of the goals of The NSW Cancer Plan 2011-2015 is to improve the quality of life of people with cancer and their carers. This project was initiated to improve the current psychosocial model of care at The Kinghorn Cancer Centre (TKCC), to better reflect an integrated, holistic and comprehensive model of patient-centred care.
March 02, 2018
Value-based health care is one of the most pressing topics in health care finance and policy today. Value-based payment structures are widely touted as critical to controlling runaway health care costs, but are often difficult for health care entities to incorporate into their existing infrastructures. Because value-based health care initiatives have bipartisan support, it is likely that these programs will continue to play a major role in both the public and private health insurance systems. As such, there is a pressing need to evaluate the implementation of these initiatives thus far and to discuss the direction that American health care financing will take in the coming years.
To explore this important issue, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School collaborated with Ropes & Gray LLP to host a one-day conference on value-based health care. This event brought together scholars, health law practitioners, and health care entities to evaluate the impact of value-based health care on the American health care system.
For more information, visit our website at: http://petrieflom.law.harvard.edu/events/details/will-value-based-care-save-the-health-care-system
March 02, 2018
Value-based health care is one of the most pressing topics in health care finance and policy today. Value-based payment structures are widely touted as critical to controlling runaway health care costs, but are often difficult for health care entities to incorporate into their existing infrastructures. Because value-based health care initiatives have bipartisan support, it is likely that these programs will continue to play a major role in both the public and private health insurance systems. As such, there is a pressing need to evaluate the implementation of these initiatives thus far and to discuss the direction that American health care financing will take in the coming years.
To explore this important issue, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School collaborated with Ropes & Gray LLP to host a one-day conference on value-based health care. This event brought together scholars, health law practitioners, and health care entities to evaluate the impact of value-based health care on the American health care system.
For more information, visit our website at: http://petrieflom.law.harvard.edu/events/details/will-value-based-care-save-the-health-care-system
Enhancing the patient experience in a new purpose-build MDT meeting room with...Cancer Institute NSW
St Vincent’s Head and Neck Clinic is a well-established, multidisciplinary clinic which has provided a co-ordinated team approach to the head and neck patient’s complex needs for over three decades. With the development of a new, purpose-built cancer facility, a clinical redesign project was undertaken, with the aim to further enhancing the patient experience and improving the quality of care for patients attending the weekly Multidisciplinary Head and Neck Clinic.
An integrated model of psychosocial cancer care: a work in progress…Cancer Institute NSW
Cancer patients are faced with a multitude of stressors, from diagnosis, through treatment, at recurrence, in the stages following treatment completion, and in the terminal phase. Psychosocial care has been highlighted as a critical aspect of providing comprehensive patient-focused care. Specifically, one of the goals of The NSW Cancer Plan 2011-2015 is to improve the quality of life of people with cancer and their carers. This project was initiated to improve the current psychosocial model of care at The Kinghorn Cancer Centre (TKCC), to better reflect an integrated, holistic and comprehensive model of patient-centred care.
March 02, 2018
Value-based health care is one of the most pressing topics in health care finance and policy today. Value-based payment structures are widely touted as critical to controlling runaway health care costs, but are often difficult for health care entities to incorporate into their existing infrastructures. Because value-based health care initiatives have bipartisan support, it is likely that these programs will continue to play a major role in both the public and private health insurance systems. As such, there is a pressing need to evaluate the implementation of these initiatives thus far and to discuss the direction that American health care financing will take in the coming years.
To explore this important issue, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School collaborated with Ropes & Gray LLP to host a one-day conference on value-based health care. This event brought together scholars, health law practitioners, and health care entities to evaluate the impact of value-based health care on the American health care system.
For more information, visit our website at: http://petrieflom.law.harvard.edu/events/details/will-value-based-care-save-the-health-care-system
March 2, 2018
Value-based health care is one of the most pressing topics in health care finance and policy today. Value-based payment structures are widely touted as critical to controlling runaway health care costs, but are often difficult for health care entities to incorporate into their existing infrastructures. Because value-based health care initiatives have bipartisan support, it is likely that these programs will continue to play a major role in both the public and private health insurance systems. As such, there is a pressing need to evaluate the implementation of these initiatives thus far and to discuss the direction that American health care financing will take in the coming years.
To explore this important issue, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School collaborated with Ropes & Gray LLP to host a one-day conference on value-based health care. This event brought together scholars, health law practitioners, and health care entities to evaluate the impact of value-based health care on the American health care system.
For more information, visit our website at: http://petrieflom.law.harvard.edu/events/details/will-value-based-care-save-the-health-care-system
What is a patient registry?
In it’s simplest form, a registry is a list of all patients in a physician’s practice who share some characteristic, such as gender, age group, or disease state. By tracking like characteristics, physicians can better organize patient’s care.
March 02, 2018
Value-based health care is one of the most pressing topics in health care finance and policy today. Value-based payment structures are widely touted as critical to controlling runaway health care costs, but are often difficult for health care entities to incorporate into their existing infrastructures. Because value-based health care initiatives have bipartisan support, it is likely that these programs will continue to play a major role in both the public and private health insurance systems. As such, there is a pressing need to evaluate the implementation of these initiatives thus far and to discuss the direction that American health care financing will take in the coming years.
To explore this important issue, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School collaborated with Ropes & Gray LLP to host a one-day conference on value-based health care. This event brought together scholars, health law practitioners, and health care entities to evaluate the impact of value-based health care on the American health care system.
For more information, visit our website at: http://petrieflom.law.harvard.edu/events/details/will-value-based-care-save-the-health-care-system
A Rare International Dialogue (Saturday May 11, 2019)
Designing Pathways to Patient-Centered Care
Bone marrow as a Vehicle for Correction of Rare Disorders: Donna Wall, The Hospital for Sick Children
In first of two-part series, Pamela Greenhouse explores the differences and similarities of the Patient and Family Centered Care Methodology and Practice (PFCC M/P) and leean process improvement approachs, such as Lean, Six Sigma and Toyota. She believes that the PFCC M/P can be the unifying theme for health care, incorporating both process improvement and performance improvement.
The best of clinical pathway redesign - practical examples of delivering bene...NHS Improvement
The examples here showcase just some of the innovations that have enabled thousands of patients to enjoy better health and well-being thanks to practicalservice improvements implemented on various clinical pathways
Presentation at the First International Symposium on Quality and Patient Safety organized by the Instituto Brasileiro para Segurança do Paciente, Sao Paulo, Brazil
The Design of Accountable Care OrganizationsCJ Fulton
Pillars for Accountable Care
PCMH versus ACOs
Core competencies
Six core structural components of successful ACO deployment
Pioneer ACO burn and learn lessons
Barriers & root cause analysis
Patient attribution
Five modes of Accountable Care
Early value-based adopters
Value discovery assessment
Modified Triple Aim
GPRO
Breakdown by 33 Measures
OHE’s Professor Nancy Devlin has researched, written and spoken widely on the use of the EQ-5D, and related measures, both in her capacity as the Director of Research at the OHE and as Chair of the Executive Committee of the EuroQol Group.
In May, Nancy was invited to participate in the “Workshop on measuring patient-reported outcomes using the EQ-5D”, which was organised by the Swedish National Board of Health and Welfare in collaboration with the EuroQol Group. The workshop brought together policy makers and researchers in Sweden interested in measuring patients’ health outcomes.
Sweden has included the EQ-5D in some of its quality registries and in population health surveys for many years. The Swedish National Board of Health and Welfare now is exploring whether and how to extend use of patient reported outcomes measures in the health care system, including the EQ-5D, to both monitor the quality of providers and services and to facilitate health technology appraisal.
Nancy’s talk, shown below, introduced the EQ-5D instrument; discussed how data from it can be analysed; identified some of the challenges in analysis; and commented on the future of outcomes measurement.
Case Study "Using Real Time Clinical Data To Support Patient Risk Stratification in The Clinical Care Setting"
HealthInfoNet operates the statewide health information exchange in Maine. The exchange currently manages clinical and patient care encounter information on 97 percent of the residents of the State of Maine. The information is gathered in real time, standardized, and aggregated at a patient specific level to support treatment. For the past three years, HealthInfoNet has worked with HBI Solutions, Inc of Palo Alto, CA to utilize this real time clinical and encounter data to support the development of predictive analytic tools that risk stratify patient populations and individual patients for future incidence of disease, cost, and both inpatient and ambulatory care encounters. These real time predictive models have now been used in clinical care settings for a year. The presentation will cover both lessons learned to date from implementing and optimizing real time predictive analytic tools and the early finding of the impact that the use of these tools is having on patient care management, utilization and outcome.
Devore Culver
Executive Director & CEO
HealthInfoNet
Introduction of the NZ Health IT Plan enables better gout management - Reflections of an early adopter. Presented by Peter Gow, Counties Manukau DHB, at HINZ 2014, 12 November 2014, 11.37am, Plenary Room
Catching Fire: Spreading Data Journalism Through the NewsroomEmma Carew Grovum
This is a talk I gave at the NICAR conference in Atlanta in spring 2015. We discussed how to get your staff in a "data state of mind" and make data stories more accessible to everyone.
March 2, 2018
Value-based health care is one of the most pressing topics in health care finance and policy today. Value-based payment structures are widely touted as critical to controlling runaway health care costs, but are often difficult for health care entities to incorporate into their existing infrastructures. Because value-based health care initiatives have bipartisan support, it is likely that these programs will continue to play a major role in both the public and private health insurance systems. As such, there is a pressing need to evaluate the implementation of these initiatives thus far and to discuss the direction that American health care financing will take in the coming years.
To explore this important issue, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School collaborated with Ropes & Gray LLP to host a one-day conference on value-based health care. This event brought together scholars, health law practitioners, and health care entities to evaluate the impact of value-based health care on the American health care system.
For more information, visit our website at: http://petrieflom.law.harvard.edu/events/details/will-value-based-care-save-the-health-care-system
What is a patient registry?
In it’s simplest form, a registry is a list of all patients in a physician’s practice who share some characteristic, such as gender, age group, or disease state. By tracking like characteristics, physicians can better organize patient’s care.
March 02, 2018
Value-based health care is one of the most pressing topics in health care finance and policy today. Value-based payment structures are widely touted as critical to controlling runaway health care costs, but are often difficult for health care entities to incorporate into their existing infrastructures. Because value-based health care initiatives have bipartisan support, it is likely that these programs will continue to play a major role in both the public and private health insurance systems. As such, there is a pressing need to evaluate the implementation of these initiatives thus far and to discuss the direction that American health care financing will take in the coming years.
To explore this important issue, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School collaborated with Ropes & Gray LLP to host a one-day conference on value-based health care. This event brought together scholars, health law practitioners, and health care entities to evaluate the impact of value-based health care on the American health care system.
For more information, visit our website at: http://petrieflom.law.harvard.edu/events/details/will-value-based-care-save-the-health-care-system
A Rare International Dialogue (Saturday May 11, 2019)
Designing Pathways to Patient-Centered Care
Bone marrow as a Vehicle for Correction of Rare Disorders: Donna Wall, The Hospital for Sick Children
In first of two-part series, Pamela Greenhouse explores the differences and similarities of the Patient and Family Centered Care Methodology and Practice (PFCC M/P) and leean process improvement approachs, such as Lean, Six Sigma and Toyota. She believes that the PFCC M/P can be the unifying theme for health care, incorporating both process improvement and performance improvement.
The best of clinical pathway redesign - practical examples of delivering bene...NHS Improvement
The examples here showcase just some of the innovations that have enabled thousands of patients to enjoy better health and well-being thanks to practicalservice improvements implemented on various clinical pathways
Presentation at the First International Symposium on Quality and Patient Safety organized by the Instituto Brasileiro para Segurança do Paciente, Sao Paulo, Brazil
The Design of Accountable Care OrganizationsCJ Fulton
Pillars for Accountable Care
PCMH versus ACOs
Core competencies
Six core structural components of successful ACO deployment
Pioneer ACO burn and learn lessons
Barriers & root cause analysis
Patient attribution
Five modes of Accountable Care
Early value-based adopters
Value discovery assessment
Modified Triple Aim
GPRO
Breakdown by 33 Measures
OHE’s Professor Nancy Devlin has researched, written and spoken widely on the use of the EQ-5D, and related measures, both in her capacity as the Director of Research at the OHE and as Chair of the Executive Committee of the EuroQol Group.
In May, Nancy was invited to participate in the “Workshop on measuring patient-reported outcomes using the EQ-5D”, which was organised by the Swedish National Board of Health and Welfare in collaboration with the EuroQol Group. The workshop brought together policy makers and researchers in Sweden interested in measuring patients’ health outcomes.
Sweden has included the EQ-5D in some of its quality registries and in population health surveys for many years. The Swedish National Board of Health and Welfare now is exploring whether and how to extend use of patient reported outcomes measures in the health care system, including the EQ-5D, to both monitor the quality of providers and services and to facilitate health technology appraisal.
Nancy’s talk, shown below, introduced the EQ-5D instrument; discussed how data from it can be analysed; identified some of the challenges in analysis; and commented on the future of outcomes measurement.
Case Study "Using Real Time Clinical Data To Support Patient Risk Stratification in The Clinical Care Setting"
HealthInfoNet operates the statewide health information exchange in Maine. The exchange currently manages clinical and patient care encounter information on 97 percent of the residents of the State of Maine. The information is gathered in real time, standardized, and aggregated at a patient specific level to support treatment. For the past three years, HealthInfoNet has worked with HBI Solutions, Inc of Palo Alto, CA to utilize this real time clinical and encounter data to support the development of predictive analytic tools that risk stratify patient populations and individual patients for future incidence of disease, cost, and both inpatient and ambulatory care encounters. These real time predictive models have now been used in clinical care settings for a year. The presentation will cover both lessons learned to date from implementing and optimizing real time predictive analytic tools and the early finding of the impact that the use of these tools is having on patient care management, utilization and outcome.
Devore Culver
Executive Director & CEO
HealthInfoNet
Introduction of the NZ Health IT Plan enables better gout management - Reflections of an early adopter. Presented by Peter Gow, Counties Manukau DHB, at HINZ 2014, 12 November 2014, 11.37am, Plenary Room
Catching Fire: Spreading Data Journalism Through the NewsroomEmma Carew Grovum
This is a talk I gave at the NICAR conference in Atlanta in spring 2015. We discussed how to get your staff in a "data state of mind" and make data stories more accessible to everyone.
AGRI MECH is one of the most reputed magazines of the Agriculture Machinery world.
This magazine will be serving among the top manufacturers, dealers,
AGRI MECH is one of the best advertising solutions in targeting all aspects and markets of agriculture when looking for any type of services or farm equipment for sale.
For more details, please contact:
Raji Naqvi
Advertisement Manager
AGRI MECH
+91 80534 35051
rkmedcom@gmail.com
Pharmacy's Emerging Role in Accountable Care Organizations (ACO)Parata Systems
Your pharmacy is an excellent partner for accountable care organizations. ACOs are formed by doctors, hospitals and other healthcare providers to improve health outcomes and lower overall medical expenses for a targeted patient population. Reimbursements are tied to patient outcomes.
ACOs’ highest-risk and highest-cost patients are those managing chronic illnesses and taking multiple medications a day. When your pharmacy can improve and track adherence – a key driver of readmission prevention and overall health – you are a valuable partner to help ACOs prevent unnecessary medical care.
Jamie Hale serves as the Chief Pharmacy Officer for Cornerstone Health Care where he is responsible for the development and integration of pharmaceutical care services in the Accountable Care Organization. He transitioned to Cornerstone in December 2012 after a 15 year career at Wake Forest Baptist Health, where he last served as Director of Pharmacy.
Download the full audio webinar at http://bit.ly/pharmacyACO.
Key Principles and Approaches to Populaiton Health mManagement - HAS Session 21Health Catalyst
Population Health Management is in its early stages of maturity, suffering from inconsistent definitions and understanding, and is overhyped by vendors and ill-defined by the industry. And yet, many systems are moving forward in innovative pioneering ways to address this growing trend. In this session, you will hear from two very different, successful health systems: a physician-led group and a large integrated delivery system. They will share their best practices, learnings, and different approaches to population health management.
Rob Reid: Redesigning primary care: the Group Health journeyThe King's Fund
Rob Reid, Senior Investigator at Group Health Research Institute, explains the journey taken by Group Health in support of integrated primary care. A case study in how primary care can be delivered effectively and efficiently to a population, Rob laid out the challenges facing general practice in the States, and how Group Health worked to improve the situation for both patients and the workforce.
Weitzman 2013 Relative patient benefits of a hospital-PCMH collaboration with...CHC Connecticut
Anuj K Dalal presents information on a PCORI research grant: Relative patient benefits of a hospital-PCMH collaboration within an ACO to improve care transitions.
Dr Jeremy Veillard: High Use in the Health Sector in Canada, 30 June 2014Nuffield Trust
In this slideshow, Dr Jeremy Veillard, Vice President, Research and Analysis, Canadian Institute for Health Information, describes how data is used in Canadian health care, describing a number of data linkage projects.
Dr Jeremy Veillard spoke at the Nuffield Trust event: The future of the hospital, in June 2014.
Apresentação realizada no I Seminário Internacional de Atenção às Condições Crônicas, pela diretora do Programa da Gestão de Doenças Crônica dos Serviços Sanitários De Alberta/Canadá, Sandra Delon.
Belo Horizonte, 11 de novembro de 2014
Two of the New York metro area’s largest provider organizations will share their experiences leveraging HIE as one of many tools to decrease fragmentation of care and improve patients’ experiences across acute and post-acute care settings for patients undergoing elective surgeries. Representatives from NYULMC and VNSNY will summarize their efforts to redesign more personalized specific care pathways and the central role played by the implementation of real-time data exchange to provide a seamless transfer of clinical data between providers caring for the patient at the time of discharge and throughout the post-acute period.
• Kathleen Mullaly - Senior Director for Clinical Operations, Department of Network Integration, NYU Langone Medical Center
• Amy Weiss - Director for Strategic Account Development, Integrated Delivery Systems, Visiting Nurse Service of New York (VNSNY)
New York eHealth Collaborative Digital Health Conference
November 18, 2014
This presentation by the Bureau of Health Information to the Royal Australasian College of Physicians looks at using clinical outcome data to improve patient care.
It examines:
Why measure and report on performance?
- Accountability and quality improvement
What is performance really?
- It is not a measure of what the system is, it is a measure of how well the system does
Whose performance is it anyway?
- Attributing results to providers, units or sectors requires a careful assessment
Overview of the Patient-Centered Outcomes Research Institute (PCORI), how PCORI views Patient-Centered Outcomes Research and how this is related to PCORI’s major funding mechanisms.
Similar to Public Reporting as a Catalyst for Better Consumer Decisions (20)
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Public Reporting as a Catalyst for Better Consumer Decisions
1. Public Reporting as a Catalyst
for Better Consumer Decisions
Ben H ar der @ benharder
A T L A S C O N F E R E N C E | B O S T O N
O C T O B E R 2 8 , 2 0 1 5
3. 3
DISCLOSURES
My Group
• U.S. News, which is the sole sponsor of my group's work, receives revenues from
multiple advertisers including health systems
Ben Harder
• Wife is a MedStar Health-employed vascular neurologist
• Sister is a Brigham & Women’s-employed neuropsychiatrist
• I plan to serve as a part-time Senior Fellow at GuideStar, a data-transparency
platform for philanthropic stakeholders
Geoff Dougherty (senior health services researcher)
• Part-time employee, fellowship recipient, and Ph.D. student in the Johns Hopkins
Bloomberg School of Public Health Department of Epidemiology
Other Co-investigators
• None disclosed
4. 4
LEARNING OBJECTIVES
Learning Objectives
• The U.S. News perspective on public reporting
• An overview of our provider look-up tool
– Doctor Finder
– Best Hospitals
• Results & future directions
– Volume, quality & referral
– Rating systems and physicians
7. 7
PERSPECTIVE ON PUBLIC REPORTING
Patient-Provider Matching and the Triple Aim
• The Triple Aim requires efficient matching of patients and providers:
• To maximize delivery of quality & value from providers to patients
• To serve the largest possible population per unit of clinical resources
• Availability of good data on provider quality & value is crucial to informed
patient decision-making.
• Ability to make meaningful comparisons among providers
• Ability to access the most-appropriate provider (must be actionable)
• Public-reporting tools – such as usnews.com – are venues for informed
patient decision-making.
• These tools are maturing rapidly
• Patient engagement with them is accelerating
• Will catalyze informed decision-making
8. 8
PERSPECTIVE ON PUBLIC REPORTING
Our Mission
To provide decision support to patients, families and referring physicians.
Patient Engagement
About 135,000 people per day – 4 million unique users per month –
access our provider-lookup tools, including Best Hospitals and Doctor
Finder. Engagement has doubled over the past two years.
Additionally, tens of thousands of consumers per day read our patient-
advice articles, evidence-based diet information, health news and more.
10. 10
HOW WE REPORT: PHYSICIANS
Doctor Finder
• Physician directory launched in 2013 & includes 800,000+ U.S. clinicians
• Data from Doximity; directory includes non-members of that network
• Target audience: Patients researching any active M.D. or D.O.
• Qualifications:
– Board certification(s)
– Specialty & subspecialty
– Education & training
– Publications
• Access factors:
– Office location
– Insurance accepted
– Hospital affiliations
– Appointment booking (via Kyruus)
12. 15
Hospital Affiliation
We show which hospitals
each physician admits to.
The physician's profile
also shows his/her
hospital(s)' quality ratings
for relevant specialties
and service lines.
Insurance Accepted
Insurance information is
shown only if proactively
reviewed by the provider.
HOW WE REPORT: PHYSICIANS
13. 13
Dorner, Jacobs & Sommers. JAMA. 2015 (Oct. 27).
• Provider networks of some ACA marketplace plans excluded endocrinologists,
psychiatrics, rheumatologists etc., according to a review of 135 plans in 34 states.
HOW WE REPORT: PHYSICIANS
14. 15
Physician-level Volumes
We recently added
physician-level volumes
for specific procedures
and diagnoses.
Physicians are called out
if they were high-volume
relative to others
performing the same
procedure or surgery.
HOW WE REPORT: PHYSICIANS
16. 16
Physician Appointment Booking
Integration of Kyruus functionality on participating hospitals’ profiles:
1) Patient inputs keywords (doctor name, specialty, diagnosis, etc.)
HOW WE REPORT: PHYSICIANS
17. 17
Physician Appointment Booking
2) At this hospital, a search for “hip replacement” returns dozens of results
3) Patient can immediately request an appointment with any physician
currently accepting new patients, if the hospital has deemed appropriate for
that clinical need.
HOW WE REPORT: PHYSICIANS
21. 21
HOW WE REPORT: COMPLEX CARE
Best Hospitals: Quality Measures
• Risk-adjusted mortality
• Patient safety score
– Not equivalent to PSI-90, which is used by CMS
• Volume of relevant complex cases
• Staffing factors (intensivist staffing, nurse staffing, Magnet status)
• Other structural measures
• Program reputation (expert medical opinion)
– Survey of board-certified physicians in relevant specialties
– RTI conducts the survey, analysis and weighting
– Two sampling frames: (1) non-members of Doximity; (2) members of Doximity
– Proportional weighting to ensure results are nationally representative
22. 22
HOW WE REPORT: COMPLEX CARE
Reputation: a (Modest) Role for Expert Clinical Opinion
• Reputational data may capture clinician-possessed information about
program quality that’s not apparent in objective data
– The essence of “expert opinion”
• Reputation acts primarily as a differentiator among exceptionally high-
performing centers
• It has relatively modest effects on which hospitals are ranked
23. 23
HOW WE REPORT: COMPLEX CARE
The Reputation Myth
• If reputation were removed from our model:
– 98% of Best Hospitals would be in the top 100 of ~5,000 hospitals evaluated
– 84% would be in the top 50
• That is: The best hospitals in a reputation-less ranking methodology
would have 84% overlap with the published Best Hospitals
24. 24
HOW WE REPORT: PEDIATRIC CARE
Best Children’s Hospitals
• Debuted in 2007
• Target audience: Families of children with complex or rare diagnoses
• Covers 10 pediatric specialties
• Classifications:
– Ranked nationally #1 to #50
– Unranked
• Past methodology refinements:
– Entirely reputational prior to 2007
– Began data collection from pediatric programs – now an 1,800-item inventory (2007)
– Data-driven rankings published in 6 specialties (2008)
– Steady increase in clinical measures, e.g. outcomes, best practices (2008–)
– Reduced reputational component to 25% (2013)
– Reduced reputational component to 16.7% (2014)
26. 26
HOW WE REPORT: PEDIATRIC CARE
Best Children’s Hospitals: Quality Measures
• Outcomes measures – at least 1 per specialty (e.g. complex heart surgery
mortality, 3-year cancer survival, rate of ICU infection)
• Best practices based on patient population (e.g. management of CF and
diabetes patients)
• Inpatient and outpatient volumes
• Staffing factors (e.g. intensivist staffing, nurse staffing, Magnet status)
• 37 structural measures including key technologies (e.g. ECMO in
Neonatology)
• Program’s reputation among pediatric specialists and subspecialists
27. 27
HOW WE REPORT: COMMON CARE
Best Hospitals for Common Care
• Debuted in May 2015
• Target audience: Typical patient facing a routine elective procedure or
managing a chronic condition that may episodically require admission
• Patient cohorts
– Hip replacement
– Knee replacement
– CABG
– CHF
– COPD
• Classifications (ratings)
– High performing
– Average
– Below average
– Low volume (non-outliers with <25 FFS cases over 3 years)
• No reputational component
28. 28
HOW WE REPORT: COMMON CARE
Best Hospitals for Common Care: Expansion Anticipated
• Common Care ratings to be updated in Spring 2016
• Analysis based on 2012-2014 inpatient claims
• Inclusion of outpatient claims in 2017
• Additional cohorts under development
– Aortic valve surgery
– Abdominal aortic aneurysm (AAA) surgery
– Lobectomy
– Colectomy
– Maternal/perinatal care (using different methods & quality indicators)
– Others for 2017 and beyond
32. 32
HOW WE REPORT
Data Limitations
• Retrospective analysis cannot adjust for all potential confounders
– Claims data may obscure variations in risk factors, coding practices, diagnostic
accuracy and appropriateness of care
• Lagging performance may not predict current performance.
– CMS recently accelerated LDS release; next public reporting will add 2013 & 2014
• Differences in setting (inpatient vs outpatient) may affect results
– We anticipate incorporating outpatient claims in 2017
• Analysis is limited primarily to Medicare FFS patients
– We will expand a voluntary program to use audited, system-submitted all-payer data
• Important outcomes, e.g. functional status, unmeasurable from claims
• Proxy measures such as volume & staffing may correlate imperfectly to
outcomes of interest
33. 33
Potential Unintended Consequences
Public reporting, like any intervention, may have unintended consequences:
• Risk aversion
• Misclassification and its consequences
• Inefficient or perverse resource allocation
– E.g., diversion of resources from clinical care, board overattentive to imperfect indicators
We are:
• Mindful of potential consequences in making analytical & publishing
decisions
• Watchful for evidence of actual unintended consequences
HOW WE REPORT
36. 36
RESULTS
Results: Outlier Frequency in U.S. News Knee Replacement Analysis
• Range: <2% (mortality) to 40% (30-day readmissions) from LDS SAF
• 4% are outliers on a CMS complications measure
KNEE
COHORT
USN Knee
Composite
USN Joint
Mortality
1-year Knee
Revisions
30-day Knee
Readmissions
CMS Joint
Complications
Better than
expected
278 (10%) 10 (0.4%) 203 (7.2%) 530 (19%) 61 (2.2%)
No different 2,301 (82%) 2,767 (98%) 2,545 (91%) 1,725 (61%) 2,635 (96%)
Worse than
expected
235 (8%) 37 (1.3%) 63 (2.2%) 559 (20%) 53 (1.9%)
37. 37
RESULTS
Results: Heart Bypass Outcomes, by STS Reporting Status
• We compared 431 hospitals practicing voluntary reporting via STS.org (as
of Feb. 2015) to 757 nonreporters that perform CABG
• Hospitals that were not voluntarily transparent had inferior outcomes
30-day
mortality
7-day
readmissions
30-day
readmissions
Avg. volume
(Medicare FFS)
Voluntarily
reporting hospitals
(n=97,751 cases)
17% lower
risk
8% lower risk 7% lower risk 75.6 cases/year
STS nonreporters
(n=118,546 cases)
— — — 52.2 cases/year
38. 38
RESULTS
Shahian et al. Annals of Surgery. 2015; 262(3):526-535
“STS programs that voluntarily participate in public reporting have
significantly higher volumes and performance. No evidence of risk
aversion was found.”
39. 39
RESULTS
Results: Heart Bypass Outcomes, by STS Status & Composite
• Nonreporting hospitals were inferior to 3-star and 2-star reporters.
• Important implications for U.S. News patient decision-support
• Important implications for provider-based data transparency
30-day
mortality
7-day
readmissions
30-day
readmissions
Avg. volume
(Medicare FFS)
STS 3-star
(n=99 hospitals)
24%
lower risk
6% lower risk 5% lower risk 110.3 cases/year
STS 2-star
(n=319 hospitals)
11%
lower risk
6% lower risk 5% lower risk 65.6 cases/year
STS 1-star
(n=11 hospitals)
lower risk
(n.s.)
0% difference
6% higher risk
(n.s.)
54.0 cases/year
Nonreporters
(n=757 hospitals)
— — — 52.2 cases/year
40. 40
TRANSPARENCY
Will More Clinical Registries Opt for Transparency?
• One observer thinks not:
“the medical priesthood [says]: ‘You are not worthy to judge us.’ ”
41. 41
TRANSPARENCY
Will More Clinical Registries Opt for Transparency?
We’re more optimistic. Our hunch:
1) Laypeople will use the decision-support tools available to them.
Currently those tools are based on claims data.
2) Medical professionals will insist on tools being valid & will provide the
best data they can, including voluntary transparency via registries.
47. 47
“It's a promising, bold move. I hope other hospitals across the
country follow.”
– Leah Binder, The Leapfrog Group
“Low-volume hobbyists are bad for patients and we have to
stop them.”
– Dr. John Birkmeyer, Dartmouth-Hitchcock
VOLUME & QUALITY
52. 52
FUTURE DIRECTIONS
Systemization and Regionalization of Care
As integrated health systems approach “maturity” – e.g. using hub-and-
spokes delivery models around centers of excellence – we anticipate
changes in:
• Referral patterns (rational referral)
• Volume at individual sites ("hub" volumes up, spokes down)
• Systemwide outcomes (improved)
• Systemwide efficiency (improved)
53. 53
Best Regional Health Systems
• Expected future manifestation of Best Regional Hospitals rankings (2011)
• Current:
– 12 complex specialty rankings – e.g. complex cancer
– 5 common service lines – Hip, Knee, CABG, CHF, COPD
– Attribution is at the level of the hospital (single site)
• Anticipated:
– Inclusion of population health, preventive health, behavioral health, etc.
– Inclusion of measures of appropriateness, efficiency, low-value care, etc.
– Attribution will migrate toward the level of the regional network (system)
• Decision support:
– Selection of provider system, of course
– With narrow networks, consumers must ‘choose’ providers when they choose a plan
– Good data will enable more-informed purchasing of health insurance
FUTURE DIRECTIONS
54. 15
Physician-level Volumes
We recently added
physician-level volumes
for specific procedures
and diagnoses.
Physicians are called out
if they were high-volume
relative to others
performing the same
procedure or surgery.
FUTURE DIRECTIONS
55. 55
Public Reporting on Physician Quality
The Volume Pledge is about quality of surgeon as well as hospital. Surgeon
quality, in particular, is of great public interest.
FUTURE DIRECTIONS
56. 56
FUTURE DIRECTIONS
Public Reporting on Physician Quality
For better or worse, we have entered an era of claimed-based reporting on
physicians. In addition, CMS will be judging physicians for P4P.
• How can we ensure patients (& payers) use valid decision-support?
We have concluded that U.S. News must develop physician ratings.
We will proceed with caution and ample communication to providers.
58. 58
FUTURE DIRECTIONS
“Others have tried and failed.
What makes you think you’ll succeed?”
Because providers, as well as patients, need us to succeed.
59. 59
FUTURE DIRECTIONS
Public Reporting on Physician Quality
Meaningful comparisons require appropriate assignment to peer group.
• E.g. a joint specialist cannot be compared to a back specialist
Within peer group, important indicators may include:
• Voluntarily reported registry data (QCDRs)
• Hospital-reported patient satisfaction (CAHPS)
• Risk-adjusted outcomes, where they can be reliably measured &
attributed
• Surgical volume as an outcome proxy
• Low-value and/or inappropriate care
• Low-value referral decisions or being embedded in low-value network
61. 61
FUTURE DIRECTIONS
Unnecessary Care
An example of the studies
we’re reading is Chen et al.
(NEJM, 2015):
“Routine preoperative testing
in not recommended for
patients undergoing cataract
surgery…
“Preoperative testing
occurred frequently and was
more strongly associated with
provider... than patient
characteristics.”
62. 62
Our Interest in Appropriateness
• Low-value care and overuse has been tolerated or incentivized for years.
• Yet it exposes patients to avoidable risk and financial toxicity.
• Population management requires radical low-valuectomy...
• ...making appropriateness a window into system performance on the Triple Aim.
A sampling of likely indicators:
• Adherence to Choosing Wisely recommendations
• Excessive low-value screening tests
• Open surgery, in cases where minimally invasive would be clinically appropriate
• Excessive C-sections, episiotomies & early elective deliveries
• Excessive interventions (e.g. elective angioplasty)
FUTURE DIRECTIONS